CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...